Ikarian Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$2.7M 83
2022
Q3
$2.7M Buy
+100,000
New +$2.7M 0.54% 28